Page last updated: 2024-12-07
tagatose 6-phosphate
Description
tagatose 6-phosphate: RN in 9th CI Form Index for alpha-D-tagatofuranose 6-(dihydrogen phosphate): 53798-20-2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
tagatose 6-phosphate : A ketohexose monophosphate that is tagatose attached to a phosphate group at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
alpha-D-tagatofuranose 6-phosphate : A D-tagatofuranose 6-phosphate with an alpha-configuration at the anomeric position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 124155 |
CHEBI ID | 47946 |
SCHEMBL ID | 9736981 |
MeSH ID | M0087278 |
Synonyms (11)
Synonym |
tagatose 6-phosphate |
alpha-d-tagatofuranose 6-phosphate |
CHEBI:47946 |
6-o-phosphono-alpha-d-tagatofuranose |
53798-20-2 |
alpha-d-tagatofuranose 6-(dihydrogen phosphate) |
alpha-d-tagatofuranose, 6-(dihydrogen phosphate) |
d-tagatose-6-phosphate |
SCHEMBL9736981 |
Q27120871 |
DTXSID701255613 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
"The rare sugar D-tagatose is a safe natural product used as a commercial food ingredient." | ( The rare sugar D-tagatose protects plants from downy mildews and is a safe fungicidal agrochemical. Akimitsu, K; Ebihara, K; Fukumoto, T; Gomi, K; Ichimura, K; Izumori, K; Mochizuki, S; Ohara, T; Ohtani, K; Shigematsu, Y; Tajima, S; Tanaka, K; Yoshihara, A, 2020) | 0.56 |
Drug Classes (1)
Class | Description |
D-tagatofuranose 6-phosphate | The furanose form of D-tagatose 6-phosphate. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (17)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 5 (29.41) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 17.56 (24.57) | Research Supply Index | 2.89 (2.92) | Research Growth Index | 5.27 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |